Amplyx Pharmaceuticals Highlights Phase 1 APX001 Data at IDWeek 2017 Pipeline Review By John Harbison|2017-10-10T10:27:26-08:00October 10, 2017|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Amplyx Pharmaceuticals Highlights Phase 1 APX001 Data at IDWeek 2017 Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
